CMA accuses pharma firms Pfizer and Flynn of charging NHS illegal prices for anti-epilepsy drug August 5, 2021 The UK’s competition watchdog has accused pharmaceutical firms Pfizer and Flynn of breaking competition law and overcharging the NHS for crucial anti-epilepsy drugs, in a new re-investigation following a years-long battle with the companies. Pfizer and Flynn “abused their dominant positions” and charged the NHS “unfairly high prices” for life-saving phenytoin sodium capsules, for which they [...]
Astrazeneca mulls offloading Covid vaccines unit even as total revenues soar above $15bn July 29, 2021 UK-listed Covid vaccine maker Astrazeneca today admitted it’s considering offloading its vaccines unit even as it cheered a 23 per cent revenue rise to $15.5bn for the first half of 2021 – boosted in part by orders for the preventative measure. A senior executive confirmed to Reuters that it is reviewing the future of the [...]
Pandemic boost: Pharmacy2U’s online product delivery climbs to 17m July 21, 2021 Pharmacy2U has delivered over 17m medicines since the start of the pandemic, figures from the Leeds-based online pharmacy showed today. The e-pharmacy, well-known for its repeat prescriptions service, has seen a sharp increase in customers ordering medicines online. The company has grown its operations to support the work of the NHS and adapt to stay-at-home [...]
Alliance Pharma revenues rise, as pandemic recovery underway July 20, 2021 Alliance Pharma reported stronger revenues for the first half of the year, as the healthcare sector continues goes from strength to strength. The international healthcare group saw revenues grow to £80.9m for the six months ended 30 June 2021 – representing an increase of just under 25 per cent, compared to the same period last [...]
Philip Morris to buy British inhaler specialist Vectura for £1bn July 9, 2021 Cigarette maker Philip Morris International will buy Vectura Group, a British pharmaceutical company, in a £1.05bn deal as it expands beyond tobacco, and into inhalers. Vectura had already agreed to a £958m deal with Carlyle Group in May but said it had withdrawn its backing for the offer which would have given shareholders 136p per share, [...]
Test and Trace: UK regulator extends approval for Innova Covid test, despite US recall June 17, 2021 Britain’s medicines regulator has extended the emergency use approval for Innova’s rapid Covid tests, used for NHS Test & Trace, after the US said they “should be thrown in the bin”. The MHRA approved the lateral flow tests for continued use, after carrying out its own checks over the last week. Innova is the UK’s [...]
US bins 60m contaminated Johnson and Johnson covid jabs June 11, 2021 Regulators in the US have ruled that 60 million doses of the Johnson & Johnson coronavirus vaccine will need to be discarded because of suspected contamination, according to reports. The doses were produced in a factory in Baltimore operated by Emergent BioSolutions, where federal regulators have been conducting a review over the course of several [...]
UK pharma Vectura snapped up by US private equity giant Carlyle for £958m May 26, 2021 UK pharma Vectura snapped up by US private equity giant Carlyle for £958m
Competition watchdog to probe Covid-19 vaccine maker AstraZeneca over £27.5bn US drug deal May 25, 2021 The UK's Competition and Markets Authority (CMA) will probe Covid-19 vaccine maker AstraZeneca's £27.5bn megadeal to buy a US drug company.
Bitter clash at Astrazeneca as 40 per cent of shareholders reject CEO pay package May 11, 2021 A share bonus hike for Astrazeneca’s chief executive was only narrowly approved in a vote where nearly 40 per cent of the pharma’s shareholders rejected the proposed pay package. The pharmaceutical giant did pass the proposal, however, which could take Pascal Soriot’s total pay, including a £1.3m salary, above the £15.4m he received last year. [...]